ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)

MM Goldbach; L Burkbauer; T Bharani; AD Williams; L Keele; J Rothman; R Jankowitz; JC Tchou

doi:10.1245/s10434-021-10353-y

ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)

MM Goldbach, L Burkbauer, T Bharani, AD Williams, L Keele, J Rothman, R Jankowitz, JC Tchou

Surgery

Research output: Contribution to journal › Editorial

Original language	American English
Pages (from-to)	501-501
Number of pages	1
Journal	Annals of Surgical Oncology
Volume	28
Issue number	SUPPL 3
DOIs	https://doi.org/10.1245/s10434-021-10353-y
State	Published - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-021-10353-y

Cite this

@article{807eb7af17b74efeb1eb174f4349f289,

title = "ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)",

author = "MM Goldbach and L Burkbauer and T Bharani and AD Williams and L Keele and J Rothman and R Jankowitz and JC Tchou",

year = "2021",

month = dec,

doi = "10.1245/s10434-021-10353-y",

language = "American English",

volume = "28",

pages = "501--501",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "SUPPL 3",

}

Goldbach, MM, Burkbauer, L, Bharani, T, Williams, AD, Keele, L, Rothman, J, Jankowitz, R & Tchou, JC 2021, 'ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)', Annals of Surgical Oncology, vol. 28, no. SUPPL 3, pp. 501-501. https://doi.org/10.1245/s10434-021-10353-y

TY - JOUR

T1 - ASO Visual Abstract

T2 - Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)

AU - Goldbach, MM

AU - Burkbauer, L

AU - Bharani, T

AU - Williams, AD

AU - Keele, L

AU - Rothman, J

AU - Jankowitz, R

AU - Tchou, JC

PY - 2021/12

Y1 - 2021/12

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000667578400002&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1245/s10434-021-10353-y

DO - 10.1245/s10434-021-10353-y

M3 - Editorial

C2 - 34181112

SN - 1068-9265

VL - 28

SP - 501

EP - 501

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - SUPPL 3

ER -

ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR plus Breast Cancer-An NCDB Analysis (2004-2016)

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this